Building an Inclusive
Clinical Studies Ecosystem to Drive Health Equity
in Europe

SEE MORE
SEE MORE

WHAT IS READI?

The READI (Research in Europe and Diversity Inclusion) Project is a public-private partnership funded by the Horizon Europe Innovative Health Initiative (IHI). It aims to create a more cohesive and inclusive ecosystem for clinical studies by ensuring the participation of underserved and underrepresented populations.
To date, clinical study results have struggled to be scientifically representative, as it frequently does not include patients who fully reflect the complete general population leading to:

THE CHALLENGES

Unequal access to health innovations for patients across Europe

Significant knowledge gaps in clinical research that affect healthcare for everyone

Preventing many US/UR populations from participating in clinical studies, reinforcing disparities in healthcare innovation and outcomes

Join us in shaping a more equitable clinical studies ecosystem where everyone has the opportunity to participate and benefit.

Want to learn more about
the project?

the readi project´s objectives

The READI Project works to address inequities in clinical studies by creating a clinical studies ecosystem where underrepresented and underserved (US/UR) populations, along with key stakeholders including patients, healthcare professionals, sites, patient organizations, regulatory agencies, Health Technology Assessment (HTAs), ethical committees and sponsors can fully participate and contribute.

KEY IMPACTS

Advancing UR and US representativeness and inclusion in clinical studies improving

SEE MORE

the readi project´s objectives

The READI Project works to address inequities in clinical studies by creating a clinical studies ecosystem where underrepresented and underserved (UR/US) populations, along with key stakeholders including patients, healthcare professionals, sites, patient organizations, regulatory agencies, Health Technology Assessment (HTAs), ethical committees and sponsors can fully participate and contribute.

KEY IMPACTS

Advancing UR and US representativeness and inclusion in clinical studies improving

SEE MORE

THE EXPERTISE BEHIND READI

SEE ALL

The consortium consists of 80 organizations from 18 countries, including pharmaceutical companies, research institutions, patient organizations, and regulatory agencies.

We prioritize the inclusion of underserved communities in clinical studies to make healthcare accessible for all.

LATEST NEWS

Scroll to Top